Synthesis and Evaluation for Anxiolytic activity of some substituted Dihydropyrazolyl- thiazoline-4-one derivatives
Abstract
Anxiolytic drugs are used for the treatment of anxiety disorders and their related psychological and physical symptoms. Today's increase in anxiolytic drug resistance has resulted in serious health issues. Thus, there is an ever-increasing demand for the design and synthesis of newer drugs for treatment. The present work reports the synthesis of some derivatives of pyrazolyl thiazolino-4-one viz. 2-[3-(furan-2-yl)-5-substituted phenyl-4,5-dihydro-1H-pyrazole-1-yl]-1,3-thiazole-4(5H)-ones. Six derivatives have been synthesized and the chemical structures were confirmed by IR, H1-NMR, and 13C-NMR. All the compounds were subjected to toxicity studies and then evaluated for their anxiolytic activity using elevated plus maze apparatus on rats. LD50 was found to be 98.11 mg/Kg. An increase in the percentage of time spent and the number of entries in the open arm of the plus maze signals a good potential for minimizing anxiety in rats. All the results were statistically tested by one-way ANOVA followed by Dunnett’s test. Compound 2; 2-[3-(furan-2-yl)-5-(4-dimethylamino- phenyl)- 4,5-dihydro-1H-pyrazol-1-yl]-1,3-thiazol-4(5H)-one and Compound 5; 2-[3-(furan-2-yl)-5-(2-chlorophenyl)-4,5-dihydro-1H-pyrazol-1-yl]-1,3-thiazol-4(5H)-one have shown percentage preference to open arm as 15.11 and 14.17 seconds and average time spent in open arm as 45.33 and 42.50 seconds respectively and thus resulted in significant anxiolytic effect as compared to control. These compounds can serve as potential leads for the development of newer therapeutic agents for the treatment of anxiety.
Keywords:
Anxiolytics, Dihydropyrazole, Thiazolino-4-one, Elevated Plus mazeDOI
https://doi.org/10.25004/IJPSDR.2022.140614References
Gallagher-Thompson D, Coon DW. Evidence-based psychological treatments for distress in family caregivers of older adults. Psychol Aging. 2007; 22(1):37-51. Available from: doi.org/10.1037/0882- 7974.22.1.37
Steffen A. Anger management for dementia caregivers: A preliminary study using video and telephone interventions. Behavior Therapy. 2000; 31:281-299. Available from: doi.org/10.1016/S0005- 7894(00)80016-7
Patrick GL. An Introduction to Medicinal Chemistr., Edn. 3, Oxford University Press, New York. 2006; pp. 271-295.
Geronikaki A, Babaev E, Dearden J, Dehaen W, Filimonov D, Galaeva I, Krajneva V, Lagunin A, Macaev F, Molodavkin G, Poroikov V, Pogrebnoi S, Saloutin V, Stepanchikova A, Stingaci E, Tkach N, Vlad L, Voronina T. Design, synthesis, computational and biological evaluation of new anxiolytics. Bioorg Med Chem. 2004; 12(24):6559- 68. Available from: doi.org/10.1016/j.bmc.2004.09.016
Qiu KM, Wang HH, Wang LM, Luo Y, Yang XH, Wang XM, Zhu HL. Design, synthesis and biological evaluation of pyrazolyl-thiazolinone derivatives as potential EGFR and HER-2 kinase inhibitors. Bioorg Med Chem. 2012; 20(6):2010-8. Available from: doi.org/10.1016/j.bmc.2012.01.051
Gokhan-Kelekci N, Koyunoglu S, Yabanoglu S, Yelekci K, Ozgen O, Ucar G, Erol K, Kendi E, Yesilada A. New pyrazoline bearing 4(3H)-quinazolinone inhibitors of monoamine oxidase: synthesis, biological evaluation, and structural determinants of MAO-A and MAO-B selectivity. Bioorg Med Chem. 2009; 17(2):675-89. Available from: doi.org/10.1016/j.bmc.2008.11.068.
Tilekar K, Upadhyay N, Meyer-Almes FJ, Loiodice F, Anisimova NY, Spirina TS, Sokolova DV, G. B. Smirnova GB, Choe J, Pokrovsky VS, Lavecchia A, Ramaa CS. Synthesis and Biological Evaluation of Pyrazoline and Pyrrolidine-2,5-dione Hybrids as Potential Antitumor Agents. Chem Med Chem. 2020; 15(19):1813-1825. Available from: doi.org/10.1002/cmdc.202000458.
Tripathi AC, Upadhyay S, Paliwal S, Saraf SK. N1-benzenesulfonyl-2- pyrazoline hybrids in neurological disorders: Syntheses, biological screening and computational studies. EXCLI J. 2018;17:126-148. Available from: doi.org/10.17179/excli2017-871.
Koc GS, Tan OU, Ucar G, Yildirim E, Erol K, Palaska E. Synthesis and Monoamine Oxidase Inhibitory Act ivit ies of some 3-(4-Fluorophenyl)-5-aryl-N-substituted-4,5-dihydro-(1H)- pyrazole-1-carbothioamide Derivatives. Drug Res (Stuttg). 2014; 64 (11) : 591-8. Available from: doi.org/10.1055/s-0033-1363997
Kariyappa AN, Rangaswamy J, Shalavadi M, Naik N, Krishnamurthy G. Synthesis and Molecular Docking of novel 1,3-Thiazole Derived 1,2,3-Triazoles and In vivo Biological Evaluation for their Anti-anxiety and Anti-inflammatory Activity. Journal of Molecular Structure. 2021; 1236(1): 130357. Available from: doi.org/10.1016/j. molstruc.2021.130357
Bhat I, Kumar A. Synthesis and anti-inflammatory activity of some novel 1, 5 benzodiazepine derivatives. Asian Journal of Pharmaceutical and Clinical Research. 2016; 9(4): 63–66.
Kulkarni SK. Handbook of Experimental Pharmacology. Edn 4, Vallabh Prakashan, New Delhi. 2012; pp. 154-156.
Published
Abstract Display: 357 
PDF Downloads: 389 
